SCHEMBL214388

SCHEMBL214388

C/C(=C\C=O)CCCC(C)CCCC(C)CCCC(C)C

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.61
LMNA P02545 1/20 0.46
BLM P54132 1/20 0.44
PTGS1 P23219 1/20 0.44
PDE4A P27815 1/20 0.44
SNCA P37840 1/20 0.44
PDE3A Q14432 1/20 0.44
KDM1A O60341 1/20 0.42
ALDH1A1 P00352 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
MEN1 O00255 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 1/20 0.40
PTPN2 P17706 1/20 0.39
CDC25B P30305 1/20 0.39
PSEN1 P49768 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31211760 1.00 PTPN1 (0.61) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL214389 1.00 PTPN1 (0.61) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL10411568 1.00 PTPN1 (0.61) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL13277591 1.00 PTPN1 (0.61) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL13277590 1.00 PTPN1 (0.61) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL10411567 1.00 PTPN1 (0.61) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL1785861 0.92 PTPN1 (0.48) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL15822466 0.92 PTPN1 (0.48) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL1785863 0.92 PTPN1 (0.48) PTPN1LMNABLMPTGS1PDE4A
SCHEMBL11667347 0.91 PTPN1 (0.59) PTPN1LMNABLMPTGS1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680020-A1 COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES FMC Agricultural Solutions A/S (DK) 2026-01-21 EP claimed
WO-2024189207-A1 COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES FMC Agricultural Solutions A/S (DK) 2024-09-19 WO claimed
US-9980937-B2 Therapeutic agent for Alzheimer's disease NAGASAKI UNIVERSITY (JP) 2018-05-29 US claimed
US-20170252318-A1 NOVEL THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE NAGASAKI UNIVERSITY (JP) 2017-09-07 US claimed
US-20060292163-A1 PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS INDIANA STATE UNIVERSITY 2006-12-28 US claimed
US-20050158329-A1 Novel phytol derived immunoadjuvants and their use in vaccine formulations GHOSH SWAPAN K (US) 2005-07-21 US claimed
EP-0309340-B1 1,3,5-NONATRIENE DERIVATIVES, THEIR PREPARATION AND USE RHONE-POULENC SANTE (FR) 1991-05-29 EP claimed
EP-4719057-A1 MICROENCAPSULATED PHEROMONE FORMULATIONS FMC Agricultural Solutions A/S (DK) 2026-04-08 EP disclosed
EP-4680020-A1 COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES FMC Agricultural Solutions A/S (DK) 2026-01-21 EP disclosed
WO-2025111184-A1 SUBSTITUTED TETRAHYDROQUINOLINE AND TETRAHYDROQUINOXALINE HERBICIDES FMC CORPORATION (US) 2025-05-30 WO disclosed
WO-2025096485-A1 LIQUID-FERTILIZER READY AGROCHEMICAL FORMULATIONS FMC CORPORATION (US) 2025-05-08 WO disclosed
WO-2024254035-A1 MICROENCAPSULATED PHEROMONE FORMULATIONS FMC Agricultural Solutions A/S (DK) 2024-12-12 WO disclosed
WO-2024189207-A1 COMPOSITIONS INCLUDING ALDEHYDES WITH IMPROVED RELEASE RATE AND DEGRADATION PROPERTIES FMC Agricultural Solutions A/S (DK) 2024-09-19 WO disclosed
US-20120264923-A1 LOW-VISCOSITY LIQUID CRYSTAL COMPOUND CHEMGENESIS INCORPORATED (JP) 2012-10-18 US disclosed
US-8088395-B2 Phytol derived immunoadjuvants and their use in vaccine formulations INDIANA STATE UNIVERSITY (US) 2012-01-03 US disclosed
US-20060292163-A1 PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS INDIANA STATE UNIVERSITY 2006-12-28 US disclosed
US-20050158329-A1 Novel phytol derived immunoadjuvants and their use in vaccine formulations GHOSH SWAPAN K (US) 2005-07-21 US disclosed
US-4876370-A 1,3,5-nonatriene derivatives, their preparation and their use RHONE-POULENC SANTE (FR) 1989-10-24 US disclosed
US-3994936-A Catalytic rearrangement HOFFMANN-LA ROCHE INC. (US) 1976-11-30 US disclosed
US-3981896-A CONVERSION OF ACETYLENIC ALCOHOLS TO ALDEHYDES AND KETONES HOFFMANN-LA ROCHE INC. (US) 1976-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170252318-A1 NOVEL THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE PSEN2, BACE1, PSEN1 PTPN1 4740/4885LMNA 615/4885BLM 4800/4885
US-20050158329-A1 Novel phytol derived immunoadjuvants and their use in vaccine formulations CD47, TSG101, LY96 PTPN1 475/4885LMNA 3976/4885BLM 1167/4885
US-20120264923-A1 LOW-VISCOSITY LIQUID CRYSTAL COMPOUND G6PD, GK, UGCG PTPN1 1106/4885LMNA 2002/4885BLM 2467/4885
US-20060292163-A1 PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS CD47, LY96, CD4 PTPN1 317/4885LMNA 3674/4885BLM 946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.